AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,678	3,347	6,587	7,284	24,377	10,132
Short-Term Investments	87,397	91,135	57,000	61,500	30,000	7,000
Cash & Short-Term Investments	93,075	94,482	63,587	68,784	54,377	17,132
Cash Growth	51.51%	48.59%	-7.56%	26.50%	217.40%	140.70%
Accounts Receivable	2,200	-	-	-	4,292	-
Other Receivables	2,220	1,634	595.17	255.83	147.07	25.71
Receivables	4,420	1,634	595.17	255.83	4,439	25.71
Prepaid Expenses	59.99	159.56	241.6	125.3	553.87	842.41
Other Current Assets	395.59	350.12	2,304	193.49	25.34	4.85
Total Current Assets	97,950	96,626	66,728	69,359	59,395	18,005
Property, Plant & Equipment	1,086	1,200	1,337	1,337	1,667	1,244
Long-Term Investments	999.95	999.95	11,000	0	0	-0
Other Intangible Assets	570.09	476.75	358.16	121.75	113.83	39.14
Other Long-Term Assets	328.53	296.28	279.23	246.39	200.58	121.15
Total Assets	100,935	99,599	79,702	71,065	61,376	19,410
Accrued Expenses	135.6	312.18	176.74	150.45	401.88	79.67
Short-Term Debt	2,919	2,740	5,472	-	-	-
Current Portion of Leases	232.46	264.11	247.12	219.84	204.68	122.43
Other Current Liabilities	5,219	5,166	15,849	1,417	3,439	19,714
Total Current Liabilities	8,506	8,482	21,746	1,787	4,045	19,916
Long-Term Leases	70.38	101.85	184.41	91.42	143.14	123.39
Other Long-Term Liabilities	27.47	26.78	24.28	24.45	22.55	12.43
Total Liabilities	8,604	8,611	21,954	1,903	4,211	20,052
Common Stock	22,486	22,436	21,574	10,561	9,180	697.51
Additional Paid-In Capital	137,612	137,481	126,746	135,659	116,365	1,715
Retained Earnings	-71,757	-72,350	-92,355	-78,226	-69,266	-16,553
Comprehensive Income & Other	3,990	3,422	1,782	1,168	887.2	363.87
Total Common Equity	92,331	90,988	57,747	69,162	57,165	-13,777
Shareholders' Equity	92,331	90,988	57,747	69,162	57,165	-641.55
Total Liabilities & Equity	100,935	99,599	79,702	71,065	61,376	19,410
Total Debt	3,222	3,106	5,904	311.26	347.82	245.82
Net Cash (Debt)	89,853	91,377	57,683	68,473	54,030	16,887
Net Cash Growth	62.73%	58.41%	-15.76%	26.73%	219.95%	145.74%
Net Cash Per Share	4060.89	4170.43	2702.58	3500.37	6479.89	4841.24
Filing Date Shares Outstanding	22.49	22.44	21.57	21.12	8.34	3.49
Total Common Shares Outstanding	22.49	22.44	21.57	21.12	8.34	3.49
Working Capital	89,444	88,144	44,982	67,572	55,350	-1,910
Book Value Per Share	4106.14	4055.51	2676.69	3274.38	6855.98	-3949.84
Tangible Book Value	91,761	90,511	57,389	69,040	57,052	-13,816
Tangible Book Value Per Share	4080.78	4034.26	2660.09	3268.62	6842.33	-3961.06
Machinery	2,528	2,493	2,176	2,072	1,908	1,333
Construction In Progress	-	-	-	-	150	150

Source: S&P Global Market Intelligence. Standard template. Financial Sources.